external-file_edited (1)_edited_edited_edited_edited.png

Hello.

Welcome to BioFocus.
Explore the latest updates from the life science industry.

London Biotechnology Show_Register Now.png

HEALTH

A New Device Could Improve How Progesterone is Delivered in Early Pregnancy

A first-in-human trial for a tampon-like intravaginal drug delivery platform arrives at a moment when England's newly published Women's Health Strategy is calling for exactly this kind of patient-centred innovation.

Featured Articles.

BIOTECH

The Future of Medicine Is In Your DNA

PHARMA

Inside Nxera Pharma’s Next-Generation Biopharma Model

BIOPROCESSING

FUJIFILM Biotechnologies Launches UK’s Largest Single-Use Biomanufacturing Facility

BIOTECH

Basecamp Research Launches the Trillion Gene Atlas

BIOTECH

Antiverse Targets Drug Discovery's "Undruggable" Frontier with AI-Driven Antibodies

HEALTH

Killing Mosquitoes With the Smell of Flowers

PHARMA

Pharma & Biotech Quality Summit 2026

SUSTAINABILITY

Engineering Crops From the Inside Out

BIOTECH

PRISM ALS Sets Out to Improve ALS/MND Drug Discovery

Latest News.

11th May, 2026

01. A New Device Could Improve How Progesterone is Delivered in Early Pregnancy

A first-in-human trial for a tampon-like intravaginal drug delivery platform arrives at a moment when England's newly published Women's Health Strategy is calling for exactly this kind of patient-centred innovation.

5th May, 2026

02 Qureight Appoints Board to Advance AI Imaging for Pulmonary Hypertension Trials

Cambridge-based imaging CRO brings together seven global experts to guide development of non-invasive AI endpoints.

28th April, 2026

03. AviadoBio Bets on Blood-Brain Barrier Technology in Push for One-Time Alzheimer's Treatment

A licensing deal with Apertura Gene Therapy gives the London-based biotech a clinically validated delivery system to pair with its gene-silencing platform, but the hard work is still ahead.

27th April, 2026

04. LEO Pharma strengthens psoriasis portfolio in China with NMPA approval of Enstilar®

NMPA approval of Enstilar® marks a key expansion for LEO Pharma in China, bringing a widely used topical psoriasis treatment to an estimated 6.5 million patients amid growing demand for innovative dermatology care.